Back to search

Article

Molecular subtyping improves prognostication of Stage 2 colorectal cancer

2019-06-18

Abstract excerpt

Post-surgical staging is the mainstay of prognostic stratification for colorectal cancer (CRC). Here, we compare TNM staging to consensus molecular subtyping (CMS) and assess the value of subtyping in addition to stratification by TNM. Three hundred and eight treatment-naïve colorectal tumours were accessed from our institutional tissue bank. CMS was carried out using tumour gene-expression data. Staging and CMS w...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a5c451d0-6882-5822-8a55-0022ed289fea
DOI
10.1101/674614
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular subtyping improves prognostication of Stage 2 colorectal cancerDOI 10.1101/674614
Molecular subtyping improves prognostication of Stage 2 colorectal cancerSemantic proximity
Interconnectivity between molecular subtypes and tumor stage in colorectal cancerSemantic proximity
Reconciliation of classification systems defining molecular subtypes of colorectal cancerSemantic proximity
Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer.Semantic proximity
Molecular-Subtype-Specific Biomarkers Improve Prediction of Prognosis in Colorectal CancerSemantic proximity
CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical modelsSemantic proximity
CMS4-focused multi-omic integration enhances antigen target identification in colorectal cancerSemantic proximity
Molecular profiling of risk factors for relapse in Japanese patients with stage II colorectal cancer: a retrospective cohort study.Semantic proximity
Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer Samples into Molecular SubtypesSemantic proximity
Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtypeSemantic proximity
Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.Semantic proximity
Consensus molecular subtyping in colon cancer: from the design of in-house assay to prognostic nomogramSemantic proximity
Select a neighboring publication to make it the new centre.